Citigroup Initiates Coverage On IDEXX Laboratories with Neutral Rating, Announces Price Target of $650
Benzinga Newsdesk 6 months ago
NewsPrice TargetInitiationAnalyst Ratings
Citigroup analyst Daniel Grosslight initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a Neutral rating and announces Price Target of $650.
Citigroup analyst Daniel Grosslight initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a Neutral rating and announces Price Target of $650.